The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Gp5  -  glycoprotein 5 (platelet)

Mus musculus

Synonyms: GP V, GPV, Glycoprotein 5, Platelet glycoprotein V
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Gp5

  • Contrary to expectations, GP V -/- platelets were normal in size and expressed normal amounts of GP Ib-IX that was functional in von Willebrand factor binding, explaining why defects in GP V have not been observed in Bernard-Soulier syndrome, a bleeding disorder caused by a lack of functional GP Ib-IX-V [1].
  • Absence of GP V also compromises thrombus stability [2].
 

High impact information on Gp5

  • Thrombosis was generated in GP V null mice only in response to catalytically inactive thrombin, whereas thrombosis occurred in both genotypes (wild type and GP V null) in response to active thrombin [3].
  • Previous analysis of platelets from GP V-null mice suggested a role for GP V as a negative modulator of platelet activation by thrombin [3].
  • Because proteolytically inactive thrombin can activate wild-type mouse and human platelets after treatment with thrombin to cleave GP V, this mechanism is involved in thrombin-induced platelet aggregation [3].
  • Consistent with these findings, GP V -/- mice had a shorter bleeding time [1].
  • MAbs against GPIb-IX, GPV, CD31, and linear epitopes on GPIIIa had mild and transient effects on platelet counts and induced no spontaneous bleeding [4].
 

Biological context of Gp5

 

Anatomical context of Gp5

 

Associations of Gp5 with chemical compounds

  • The observation that collagen does not behave like CRP in platelets expressing reduced levels of GPVI, even in the combined presence of blocking antibodies against integrin alpha2beta1 and GPV, suggests that collagen has a greater affinity than CRP for GPVI, and/or that other receptors are involved in its binding to platelets [9].
  • The chimeric pGMokPV encoded the NH2 part of GMok and the COOH part of GPV [10].
 

Analytical, diagnostic and therapeutic context of Gp5

References

  1. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Ramakrishnan, V., Reeves, P.S., DeGuzman, F., Deshpande, U., Ministri-Madrid, K., DuBridge, R.B., Phillips, D.R. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  2. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Ni, H., Ramakrishnan, V., Ruggeri, Z.M., Papalia, J.M., Phillips, D.R., Wagner, D.D. Blood (2001) [Pubmed]
  3. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Ramakrishnan, V., DeGuzman, F., Bao, M., Hall, S.W., Leung, L.L., Phillips, D.R. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  4. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Nieswandt, B., Bergmeier, W., Rackebrandt, K., Gessner, J.E., Zirngibl, H. Blood (2000) [Pubmed]
  5. Cloning and characterization of the gene encoding the murine glycoprotein V: the conserved thrombin-cleavable protein on platelet surface. Katsutani, S., Fujimoto, T.T., Noda, M., Shimomura, T., Takafuta, T., Kimura, A., Fujimura, K. Thromb. Res. (1998) [Pubmed]
  6. Functional conservation of platelet glycoprotein V promoter between mouse and human megakaryocytes. Sato, N., Kiyokawa, N., Taguchi, T., Suzuki, T., Sekino, T., Ohmi, K., Itagaki, M., Sato, T., Lepage, A., Lanza, F., Fujimoto, J. Exp. Hematol. (2000) [Pubmed]
  7. Ultrastructural analysis of megakaryocytes in GPV knockout mice. Poujol, C., Ramakrishnan, V., DeGuzman, F., Nurden, A.T., Phillips, D.R., Nurden, P. Thromb. Haemost. (2000) [Pubmed]
  8. Characterization of monoclonal antibodies against mouse and rat platelet glycoprotein V (CD42d). Sato, N., Kiyokawa, N., Takada, K., Itagaki, M., Saito, M., Sekino, T., Suzuki, T., Taguchi, T., Mimori, K., Lanza, F., Fujimoto, J. Hybridoma (2000) [Pubmed]
  9. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands. Snell, D.C., Schulte, V., Jarvis, G.E., Arase, K., Sakurai, D., Saito, T., Watson, S.P., Nieswandt, B. Biochem. J. (2002) [Pubmed]
  10. DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Bahloul, C., Jacob, Y., Tordo, N., Perrin, P. Vaccine (1998) [Pubmed]
 
WikiGenes - Universities